AU2000265105A1 - Methods and compositions for the prevention and treatment of syndrome x - Google Patents

Methods and compositions for the prevention and treatment of syndrome x

Info

Publication number
AU2000265105A1
AU2000265105A1 AU2000265105A AU6510500A AU2000265105A1 AU 2000265105 A1 AU2000265105 A1 AU 2000265105A1 AU 2000265105 A AU2000265105 A AU 2000265105A AU 6510500 A AU6510500 A AU 6510500A AU 2000265105 A1 AU2000265105 A1 AU 2000265105A1
Authority
AU
Australia
Prior art keywords
syndrome
prevention
compositions
treatment
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2000265105A
Inventor
Michael Menard
Susie Rockway
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PharmaNutrients Inc
Original Assignee
PharmaNutrients Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PharmaNutrients Inc filed Critical PharmaNutrients Inc
Publication of AU2000265105A1 publication Critical patent/AU2000265105A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2000265105A 2000-08-02 2000-08-02 Methods and compositions for the prevention and treatment of syndrome x Abandoned AU2000265105A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2000/021044 WO2002009691A1 (en) 2000-08-02 2000-08-02 Methods and compositions for the prevention and treatment of syndrome x

Publications (1)

Publication Number Publication Date
AU2000265105A1 true AU2000265105A1 (en) 2002-02-13

Family

ID=21741650

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2000265105A Abandoned AU2000265105A1 (en) 2000-08-02 2000-08-02 Methods and compositions for the prevention and treatment of syndrome x

Country Status (5)

Country Link
US (1) US7208522B1 (en)
EP (1) EP1305017A4 (en)
JP (1) JP2004505041A (en)
AU (1) AU2000265105A1 (en)
WO (1) WO2002009691A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002024180A2 (en) 2000-09-21 2002-03-28 Nutrition 21, Inc. Chromium containing compositions for the treatment of diabetes, the reduction of body fat, improvement of insulin sensitivity and reduction of hyperglycemia and hypercholesteremia
US7666447B2 (en) 2004-10-08 2010-02-23 Pharmanutrients Compositions including Krill extracts and conjugated linoleic acid and methods of using same
US8853192B2 (en) 2006-08-11 2014-10-07 Kao Corporation Fat or oil composition

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4981844A (en) 1988-10-04 1991-01-01 University Of Cincinnati Method to improve immune response and resistance to infection following surgery by diet composition
GB9403857D0 (en) 1994-03-01 1994-04-20 Scotia Holdings Plc Fatty acid derivatives
PT843972E (en) * 1996-11-20 2002-12-31 Nutricia Nv NUTRITIVE COMPOSITION THAT INCLUDES FATS FOR THE TREATMENT OF METABOLIC SYNDROME
IL121165A0 (en) * 1997-06-26 1997-11-20 Yissum Res Dev Co Pharmaceutical compositions containing carboxylic acids and derivatives thereof
AU1911999A (en) 1997-12-12 1999-06-28 Penn State Research Foundation, The Methods and compositions for treating diabetes
US6060514A (en) 1998-05-04 2000-05-09 Conlin Co., Inc. Isomer enriched conjugated linoleic acid compositions
US6214820B1 (en) * 1998-10-21 2001-04-10 Novo Nordisk A/S Compounds, their preparation and use
JP2003508389A (en) * 1999-08-27 2003-03-04 エリ リリー アンド カンパニー Biaryl-oxa (thia) zole derivatives and their use as PPAR modulators
US6509374B2 (en) * 2000-04-17 2003-01-21 Novo Nordisk A/S Compounds, their preparation and use

Also Published As

Publication number Publication date
WO2002009691A1 (en) 2002-02-07
EP1305017A4 (en) 2004-01-14
JP2004505041A (en) 2004-02-19
US7208522B1 (en) 2007-04-24
EP1305017A1 (en) 2003-05-02

Similar Documents

Publication Publication Date Title
AU4205100A (en) Methods and compositions for the treatment of pancreatitis
AU2001239052A1 (en) Compositions for prevention and treatment of dementia
AUPR105400A0 (en) Processes and compositions for water treatment
AU2002243023A1 (en) Compositions for preventing and/or treating oral diseases
AU4340700A (en) Methods and compositions for use in the treatment of hyperlipidemia
AU2002225894A1 (en) Methods and compositions for the control of coccidiosis
AU2001250821A1 (en) Methods and compositions for the treatment and prevention of erectile dysfunction
AU4136901A (en) Novel methods for the treatment and prevention of dizziness and pruritus
AU5006499A (en) Compositions and methods for the treatment or prevention of pulmonary infections
AU2756301A (en) Compositions comprising genome segments and methods of using the same
AU2002239258A1 (en) Houttuyninum compositions and methods for inhibiting the activity of erbb-2 based thereon
AU2001264522A1 (en) Methods and compositions for the prevention of myopia
AU2002346882A1 (en) Methods for the treatment of osteoarthritis and compositions thereof
AU4228000A (en) Methods and compositions for the treatment and prevention of lung disease
AU2002303552A1 (en) Methods and compositions for prevention of angioproliferation
AU2002366809A1 (en) Syn3 compositions and methods
AUPR809001A0 (en) Compositions for the treatment and prevention of plant pathogens
AU2001255730A1 (en) Methods and compositions for the treatment of cardiac indications
AU2000265105A1 (en) Methods and compositions for the prevention and treatment of syndrome x
AU4225500A (en) Methods and compositions for the treatment and prevention of lung disease
AU2002222125A1 (en) Prevention and treatment of tachyphylactic response
AU2001255168A1 (en) Compositions and methods for the treatment of immune related diseases
AU2002241162A1 (en) Intimins in the prevention or treatment of infections:ii
AU2002359869A1 (en) Pak5-related compositions and methods
AUPQ501000A0 (en) Compositions for the prevention and treatment of influenza